Requires FDA to update rules for drug testing, allowing more non-animal methods.
This bill would require the Food and Drug Administration (FDA) to update its rules for how new drugs are tested. It would replace old language about 'animal' tests with 'nonclinical' tests, which includes non-animal methods. This change would help drug developers use a wider range of testing approaches.
Today, federal regulations still refer to "animal" tests for drug development, even though a recent law allows broader "nonclinical" testing methods. If this bill becomes law, the FDA would be required to update these regulations within one year. They would replace "animal" with "nonclinical" in many sections and add a definition for "nonclinical test," officially recognizing a wider range of testing approaches.
HR 2821 · 119th Congress · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
8 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.